Subramanian Sanjay 4
4 · Inozyme Pharma, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Award
Common Stock
2023-09-29$3.57/sh+2,319$8,279→ 30,398 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2023 through September 30, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on September 29, 2023, the last trading day of the purchase period.